This other transaction agreement for prototype is for the development of molnupiravir as an oral therapeutic for treatment of venezuelan equine encephalitis virus.
Other Transaction IDV Awarded Last action
- Contract number
- W911SR2590001
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $39,111,329.00
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
The Joint PEO Chemical and Biological Defense awarded an Other Transaction Agreement for Prototype to Merck Sharp & Dohme LLC with a ceiling of $39.1 million on March 14, 2025, to develop molnupiravir as an oral therapeutic for treatment of Venezuelan Equine Encephalitis Virus. Other Transactions operate outside the FAR framework and are statutorily authorized to accelerate prototype development and evaluation.
Merck is a pharmaceutical manufacturer specializing in vaccines, specialty therapeutics, and medical countermeasures with established federal relationships across the Department of Defense, Department of Veterans Affairs, CDC, and HHS. The company holds no small business certifications and competes on a full-and-open, non-set-aside basis. This OT IDV represents Merck's primary vehicle for accelerated development of antivirals targeting high-consequence biological threats within the chemical and biological defense portfolio.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$820,000 | |
| Funding Only Action | -$3,200,000 | |
| Funding Only Action | -$95,000 | |
| Supplemental Agreement for work within scope | $3,767,983 | |
| Funding Only Action | $2,868,227 | |
| Original award | $300,000 |
Quick answers
Who was awarded contract W911SR2590001?
W911SR2590001 was awarded to Merck Sharp & Dohme LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on March 14, 2025.
How much is contract W911SR2590001 worth?
W911SR2590001's own ceiling is $39,111,329.
Which agency awarded contract W911SR2590001?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2590001, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR2590001 competed?
The extent of competition for W911SR2590001 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV